GlassScriptPhysician profile
Breeann N Wilson
NPI 1255573887
$9,251.53
in general payments reported to CMS, 2019-2025
32 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,331 · 2020: $1,042 · 2021: $1,376 · 2022: $873 · 2023: $1,235 · 2024: $865 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,567 · Education: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,567.28 |
| Education | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,443.24 | 2019-2023 | Anchorage, Actishield, Hoffmann |
| Treace Medical Concepts, INC. | $800.44 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $524.86 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $384.25 | 2019-2024 | Renasys Go V2 Home, Pico, Collagenase Santyl |
| Organogenesis INC. | $347.93 | 2019-2024 | Affinity, Puraply Wound Matrix, Nushield |
| Bioventus LLC | $298.83 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Next Science LLC | $288.24 | 2023-2024 | Blastx, Xperience, Surgx |
| Amgen INC. | $246.64 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $246.54 | 2019-2023 | Krystexxa |
| Integra Lifesciences Corporation | $214.53 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $191.42 | 2025 | Physio-Stim |
| Abbott Laboratories | $188.13 | 2019-2025 | Octrode, Axium |
| Kerecis Limited | $175.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Grt US Holding, INC. | $160.64 | 2022 | |
| Innovation Technologies INC | $157.77 | 2023 | Irrisept |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $115.27 | 2023 | |
| Biopoly LLC | $105.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $44.47 | 2025 | Tapestry |
| Averitas Pharma INC. | $37.06 | 2023 | Qutenza |
| Melinta Therapeutics, LLC | $35.46 | 2019-2021 | |
| Bsn Medical INC | $33.33 | 2024-2025 | |
| Advanced Oxygen Therapy INC. | $31.39 | 2019-2023 | Topical Oxygen Chamber For Extremities |
| Musculoskeletal Transplant Foundation INC. | $28.78 | 2021-2023 | |
| Paragon 28, INC. | $25.47 | 2022 | |
| Medtronic, INC. | $22.31 | 2024 | Intellis Adaptivestim |
| Prodigy Surgical Distribution, INC. | $19.32 | 2025 | |
| Ibsa Pharma INC. | $16.19 | 2024 | Tirosint, Licart |
| Solventum Corporation | $15.40 | 2024 | Kerramax Care |
| Arthrosurface Incorporated | $14.37 | 2019 | |
| Baudax Bio INC. | $13.82 | 2022 | |
| Merck Sharp & Dohme LLC | $12.64 | 2019 | |
| Kci USA, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breeann Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.